Search results for "vaccine."

showing 10 items of 789 documents

IL-12 Expands and Differentiates Human Vγ2Vδ2 T Effector Cells Producing Antimicrobial Cytokines and Inhibiting Intracellular Mycobacterial Growth

2019

While IL-12 plays a key role in differentiation of protective CD4+ Th1 response, little is known about mechanisms whereby IL-12 differentiates other T-cell populations. Published studies suggest that predominant Vγ2Vδ2 T cells in humans/nonhuman primates (NHP) are a fast-acting T-cell subset, with capacities to rapidly expand and produce Th1 and cytotoxic cytokines in response to phosphoantigen (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP) produced by Mycobacterium tuberculosis (Mtb) or others. However, whether IL-12 signaling pathway mediates fast-acting and Th1 or anti-microbial features of Vγ2Vδ2 T cells remains poorly defined. Here, we show that IL-12, but not other IL-12 fami…

lcsh:Immunologic diseases. AllergyCells1.1 Normal biological development and functioningproliferationImmunologyLymphocyte ActivationV gamma 2V delta 2 T cellsVaccine Related03 medical and health sciencesPhosphatidylinositol 3-Kinases0302 clinical medicineRare DiseasesUnderpinning researchT-Lymphocyte SubsetsImmunology and AllergyTuberculosis2.1 Biological and endogenous factorsHumansAetiologyIntraepithelial LymphocytesCells Cultured030304 developmental biologyOriginal Researchanti-tuberculosis0303 health sciencesCulturedVγ2Vδ2 T cellsTumor Necrosis Factor-alphaInflammatory and immune systemCorrectionCell DifferentiationMycobacterium tuberculosisdifferentiationSTAT4 Transcription FactorTh1 CellsInterleukin-12Organophosphates3. Good healthInfectious DiseasesGood Health and Well BeingMedical MicrobiologyIL-12Infectionlcsh:RC581-607Proto-Oncogene Proteins c-akt030215 immunologySignal TransductionFrontiers in Immunology
researchProduct

Report from the second cytomegalovirus and immunosenescence workshop

2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.; International audience; The Second International Workshop on CMV & Immunosenescence was held in Cambridge, UK, 2-4th December, 2010. The presentations covered four separate sessions: cytomegalovirus and T cell phenotypes; T cell memory frequency, inflation and immunosenescence; cytomegalovirus in aging, mortality and disease states; and the immunobiology of cytomegalovirus-specific T cells and effects of the virus on vacc…

lcsh:Immunologic diseases. AllergyGerontologyAging[SDV.IMM] Life Sciences [q-bio]/Immunology[SDV]Life Sciences [q-bio]ImmunologyCongenital cytomegalovirus infectionDiseaseAgeing CMV immunitylcsh:Geriatrics0601 Biochemistry and Cell BiologyVaccine Related03 medical and health sciences0302 clinical medicineSDG 3 - Good Health and Well-beingMedicinecytomegalovirusComputingMilieux_MISCELLANEOUS030304 developmental biologyimmunosenescence0303 health sciencesbusiness.industryGeriatrics gerontologyImmunosenescencemedicine.disease3. Good healthlcsh:RC952-954.6AgeingHCMV InfectionInfectious DiseasesCommentary/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IMM]Life Sciences [q-bio]/ImmunologyImmunizationlcsh:RC581-607business030215 immunology
researchProduct

How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines

2015

In the last decades, tremendous advancement in dissecting the mechanisms of pathogenicity ofNeisseria meningitidisat a molecular level has been achieved, exploiting converging approaches of different disciplines, ranging from pathology to microbiology, immunology, and omics sciences (such as genomics and proteomics). Here, we review the molecular biology of the infectious agent and, in particular, its interactions with the immune system, focusing on both the innate and the adaptive responses. Meningococci exploit different mechanisms and complex machineries in order to subvert the immune system and to avoid being killed. Capsular polysaccharide and lipooligosaccharide glycan composition, in…

lcsh:Immunologic diseases. AllergyImmunologyGenomicsMeningococcal VaccinesMeningococcal vaccineReview ArticleBiologyMeningitis MeningococcalNeisseria meningitidisProteomicsmedicine.disease_causeImmune systemAntigenConjugate vaccineImmunityAnimals; Gram-Negative Bacteria; Host-Pathogen Interactions; Humans; Immunity; Meningitis Meningococcal; Meningococcal Vaccines; Neisseria meningitidis; Immune System; Immunology and Allergy; ImmunologyGram-Negative BacteriamedicineAnimalsHumansImmunology; Immunology and AllergyImmunology and AllergyNeisseria meningitidisImmunityGeneral MedicineVirologyImmune SystemHost-Pathogen Interactionslcsh:RC581-607
researchProduct

Antigen-specific T cells and cytokines detection as useful tool for understanding immunity against zoonotic infections.

2012

Zoonoses include a broad range of diseases, that are becoming of great interest, due to the climate changing, that cause the adaptation of vectors to new niches and environments. Host immune responses play a crucial role in determining the outcome of infections, as documented by expansion of antigen-specific T cells during several zoonotic infections. Thus, understanding of the contribution of antigen-specific T-cell subsets in the host immune response is a powerful tool to evaluate the different immunological mechanisms involved in zoonotic infections and for the development of effective vaccines. In this paper we discuss the role of T cells in some eukaryotic and prokaryotic infectious mo…

lcsh:Immunologic diseases. AllergyNematodaT-LymphocytesImmunologyReview ArticleAdaptive ImmunityBiologyHost-Parasite InteractionsImmune systemT-Lymphocyte SubsetsAntigen specificImmunityZoonosesAnimalsHumansImmunology and AllergyAntigensTh1-Th2 BalanceZoonoses antigen specific T-cells animal immunology.VaccinesBacteriaZoonotic InfectionGeneral MedicineAcquired immune systemVirologyImmunity InnateHost-Pathogen InteractionsImmunologyCytokinesAdaptationlcsh:RC581-607
researchProduct

Current Progress in Particle-Based Systems for Transdermal Vaccine Delivery

2020

Transcutaneous immunization (TCI) via needle-free and non-invasive drug delivery systems is a promising approach for overcoming the current limitations of conventional parenteral vaccination methods. The targeted access to professional antigen-presenting cell (APC) populations within the skin, such as Langerhans cells (LCs), various dermal dendritic cells (dDCs), macrophages, and others makes the skin an ideal vaccination site to specifically shape immune responses as required. The stratum corneum (SC) of the skin is the main penetration barrier that needs to be overcome by the vaccine components in a coordinated way to achieve optimal access to dermal APC populations that induce priming of…

lcsh:Immunologic diseases. AllergyOvalbuminMini ReviewT-Lymphocytesparticulate systemsImmunologyAntigen-Presenting CellsAdministration CutaneousSonicationDrug Delivery SystemsImmune systemtranscutaneous immunizationAdjuvants ImmunologicAntigenvaccine particlesStratum corneumHumansImmunology and AllergyMedicineVaccines Virus-Like ParticleParticle SizeTransdermalIontophoresisintegumentary systembusiness.industryElectroporationVaccinationDermisPeptide Fragmentsneedle-free vaccinationVaccinationElectroporationmedicine.anatomical_structureLangerhans CellsLiposomesImmunologyDrug deliverydrug deliveryInjections JetnanoparticlesLymph NodesPharmaceutical Vehiclesbusinesslcsh:RC581-607Frontiers in Immunology
researchProduct

Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy

2017

Recent preclinical and clinical studies have proved the long-standing hypothesis that tumors elicit adaptive immune responses and that the antigens driving effective T-cell response are neoantigens, i.e., peptides that are generated from somatically mutated genes. Hence, the characterization of neoantigens and the identification of the immunogenic ones are of utmost importance for improving cancer immunotherapy and broadening its efficacy to a larger fraction of patients. In this review, we first introduce the methods used for the quantification of neoantigens using next-generation sequencing data and then summarize results obtained using these tools to characterize the neoantigen landscape…

lcsh:Immunologic diseases. Allergyimmunoeditingintegumentary systemImmunologytumor heterogeneityImmunology and Allergysomatic mutationsnext-generation sequencingReviewlcsh:RC581-607cancer vaccinesFrontiers in Immunology
researchProduct

Multicompartmental Lipopolyplex as Vehicle for Antigens and Genes Delivery in Vaccine Formulations

2021

Vector design and its characterization is an area of great interest in current vaccine research. In this article, we have formulated and characterized a multicompartmental lipopolyplex, which associates multiple liposomes and polyplexes in the same complex. These particles allow the simultaneous delivery of lipid or water-soluble antigens associated with genes to the same cell, in much higher amounts than conventional lipopolyplexes. The vector characterization and optimization were carried out using liposomes with entrapped carboxyfluorescein and adapted electrophoretic assays. Two types of lipopolyplexes (containing hydrophilic or lipophilic antigens) were employed to evaluate their inter…

liposomesFarmacologiaCelllcsh:RS1-441Pharmaceutical Science02 engineering and technology010402 general chemistry01 natural sciencesArticlelipopolyplexeslcsh:Pharmacy and materia medicaImmune systemAntigenvaccinemedicinemelanomaVacunacióVector (molecular biology)Melanomamulticompartmental lipopolyplexesLiposomebiologyChemistryMelanoma021001 nanoscience & nanotechnologymedicine.disease0104 chemical sciencesVaccinationmedicine.anatomical_structureBiochemistrynon-viral gene transferbiology.proteinantitumor immunizationAntibody0210 nano-technologyPharmaceutics
researchProduct

French Vaccine Pass to the Test of the Constitutional Council: Some Considerations in the Light of the European Convention on Human Rights

2022

On 21 January 2022 the French Constitutional Council issued a ruling on the constitutionality of the law which aimed to make the access to a very large number of places subject to a vaccine pass. Firstly, the essay illustrates the main points of the ruling with a particular focus on the legal criteria which constituted the parameters used by the French Constitutional Council, including a short explanation of the legal provisions rejected. The article then analyses the most recent judgement of the European Court of Human Rights (ECtHR) which regarded mandatory vaccinations. Specifically, the judgment focuses on the recent case Vavři¹ka and Others v. the Czech Republic which explained the mai…

mandatory vaccinationessence of rightEuropean Court of Human Rightderogation in time of emergencySettore IUS/13 - Diritto Internazionalehealth pavaccine pa
researchProduct

Self-adjuvanting synthetic antitumor vaccines from MUC1 glycopeptides conjugated to T-cell epitopes from tetanus toxoid.

2013

The T-helper epitope peptide P30 (green in the scheme) from tetanus toxoid was used as the immunostimulant in MUC1 glycopeptide antitumor vaccines and apparently also acts as a built-in adjuvant. P30-conjugated glycopeptide vaccines containing three glycans in the immunodominant motifs PDTRP and GSTAP induced much stronger immune responses and complement dependent cytotoxicity mediated killing of tumor cells when applied in plain PBS solution without complete Freund's adjuvant.

medicine.drug_classmedicine.medical_treatmentEpitopes T-Lymphocytecomplex mixturesImmunostimulantCancer VaccinesCatalysisEpitopeEpitopesImmune systemmedicineTetanus ToxoidHumansTetanusChemistryMucin-1ToxoidGlycopeptidesGeneral Chemistrymedicine.diseaseVirologyComplement-dependent cytotoxicityGlycopeptideEpitopes B-LymphocytePeptidesAdjuvantAngewandte Chemie (International ed. in English)
researchProduct

A Synthetic Glycopeptide Vaccine for the Induction of a Monoclonal Antibody that Differentiates between Normal and Tumor Mammary Cells and Enables th…

2015

In studies within the realm of cancer immunotherapy, the synthesis of exactly specified tumor-associated glycopeptide antigens is shown to be a key strategy for obtaining a highly selective biological reagent, that is, a monoclonal antibody that completely differentiates between tumor and normal epithelial cells and specifically marks the tumor cells in pancreas tumors. Mucin MUC1, which is overexpressed in many prevalent cancers, was identified as a promising target for this strategy. Tumor-associated MUC1 differs significantly from that expressed by normal cells, in particular by altered glycosylation. Structurally defined tumor-associated MUC1 cannot be isolated from tumor cells. We synt…

medicine.drug_classmedicine.medical_treatmentTumor M2-PKBreast NeoplasmsBiology010402 general chemistryMonoclonal antibody01 natural sciencesCancer VaccinesCatalysisCancer immunotherapyAntigenPancreatic tumorPancreatic cancermedicineHumansBreastMUC1010405 organic chemistryMucinGlycopeptidesAntibodies MonoclonalGeneral Chemistrymedicine.diseaseMolecular biology0104 chemical sciencesPancreatic NeoplasmsFemaleAngewandte Chemie (International ed. in English)
researchProduct